aid: egenesisbio accessModel: pricing: unknown onboarding: unknown trial: false try_now: false public: false label: Unknown confidence: low source: [] generated: '2026-07-22' method: derived image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/egenesisbio.png name: eGenesis description: eGenesis is a clinical-stage biotechnology company based in Cambridge, Massachusetts, developing human-compatible, genetically engineered organs to address the global organ shortage. Using a proprietary CRISPR-based multiplex genome-editing platform, eGenesis modifies the porcine genome to inactivate endogenous retroviruses and add protective human transgenes, producing pig kidneys, livers, and hearts intended for xenotransplantation. Its lead program, EGEN-2784, is a genetically engineered porcine kidney being evaluated in an expanded-access study. This API Evangelist profile tracks the company; eGenesis publishes no public developer API. url: https://raw.githubusercontent.com/api-evangelist/egenesisbio/refs/heads/main/apis.yml x-type: company x-source: vc-portfolio x-backed-by: - khosla-ventures x-tier: stub x-tier-reason: portfolio-lead specificationVersion: '0.20' created: '2026-07-17' modified: '2026-07-19' tags: - Company - Biotechnology - Xenotransplantation - Gene Editing - CRISPR - Organ Transplant - Healthcare - Life Sciences apis: [] maintainers: - FN: Kin Lane email: kin@apievangelist.com - FN: APIs.json email: info@apis.io common: - type: DomainSecurity url: security/egenesisbio-domain-security.yml - type: Website url: https://www.egenesisbio.com/ - type: About url: https://egenesisbio.com/about - type: Blog url: https://egenesisbio.com/news-media - type: Support url: https://egenesisbio.com/contact - type: TermsOfService url: https://egenesisbio.com/terms-of-use - type: PrivacyPolicy url: https://egenesisbio.com/privacy-policy x-enrichment: date: '2026-07-19' status: backfilled pass: local-v1 note: backfilled from .gitignore signal + verified work evidence